Scaled average bioequivalence methods for highly variable drugs: leveling-off soft limits and the EMA's 2010 guideline (some ways to improve its type I error control) (Q6618434)
From MaRDI portal
 | This is the item page for this Wikibase entity, intended for internal use and editing purposes. Please use this page instead for the normal view: Scaled average bioequivalence methods for highly variable drugs: leveling-off soft limits and the EMA's 2010 guideline (some ways to improve its type I error control) |
scientific article; zbMATH DE number 7925860
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Scaled average bioequivalence methods for highly variable drugs: leveling-off soft limits and the EMA's 2010 guideline (some ways to improve its type I error control) |
scientific article; zbMATH DE number 7925860 |
Statements
Scaled average bioequivalence methods for highly variable drugs: leveling-off soft limits and the EMA's 2010 guideline (some ways to improve its type I error control) (English)
0 references
14 October 2024
0 references
interval inclusion principle
0 references
point estimate constraint
0 references
scaled average bioequivalence
0 references
